Paradigm BiopharmaceuticalsPAR 
$0.16-2.08%24h
-2.08%24h
Global rank24637
Market cap$46.20M
Change 7d0.00%
YTD Performance-46.59%
SP500 benchmarkUnderperform
P/E-0.89
P/S1455.83
Revenue$31.73K
Earnings-$35.23M
Dividend yield-
Main Sector
Healthcare
Paradigm Biopharmaceuticals PAR Total Debt
PAR Total Debt in 2022: $160.62K
According to Paradigm Biopharmaceuticals latest financial reports the total debt is $160.62K, an decrease of -49.52% to 2022. At the end of 2022 company had $318.20K total debt. This figure represents the debts and financial obligations that Paradigm Biopharmaceuticals combine short-term debt, long-term debt, and other fixed payment obligations (such as capital leases) of a business that are incurred while under normal operating cycles.
Paradigm Biopharmaceuticals PAR Total Debt History from 2023 to 2022
-
Value:-
PAR Total Debt by year
| Year | Total debt | Change |
|---|---|---|
| 2023 | $160.62K | -49.52% |
| 2022 | $318.20K | -24.03% |
| 2021 | $418.85K | -17.59% |
| 2020 | $508.24K | - |
View the Top Total Debt Stocks 
